Ed Jarbath

• Over fifteen years of pharmaceutical industry experience
• Previously Director of Oncology Commercial Development with Pharmacia Corporation, and responsible for COX-2 inhibition as a platform for cancer treatment and prevention
• Former Associate Director for worldwide marketing for Celebrex, responsible for product launch (across eighteen countries) and medical communication including the creation of a groundbreaking platform for the advancement of treatment and education in arthritis and pain for the global medical community
• Has held sales, finance, market research, and marketing positions with GlaxoSmithKline and Monsanto’s Searle Pharmaceutical business unit
• MBA from the McColl School of Business at Queens University, Charlotte, NC
• M.S. technology management from The Wharton School and the School of Engineering and Applied Sciences of The University of Pennsylvania

Andrew Whelton, MD

• Professor of Medicine (Adjunct), The Johns Hopkins University School of Medicine, Baltimore, Maryland
• Former Director of The Clinical Division of Nephrology at The Johns Hopkins University School of Medicine
• Long term faculty member of the Johns Hopkins University School of Medicine and served as Executive Vice President of the Finch University of Health Sciences/The Chicago Medical School
• Respected thought leader, accomplished speaker and author of more than 350 scientific articles and book chapters in leading medical publications
• Member of numerous scientific and academic organizations and past President of The American College of Clinical Pharmacology
• Founding member of the American Board of Clinical Pharmacology, former Chairman of the Commission on Kidney Disease of the State of Maryland and Special Government Officer consultant for the U.S.FDA

To register for news and updates about ScienceFirst, click here >>>